HAG
HighPoint Advisor Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-613
| Closed | -$226K | – | 703 |
|
|
2024
Q3 | $226K | Buy |
+613
| New | +$226K | 0.01% | 580 |
|
|
2024
Q1 | – | Sell |
-609
| Closed | -$208K | – | 652 |
|
|
2023
Q4 | $208K | Buy |
+609
| New | +$208K | 0.01% | 581 |
|
|
2022
Q2 | $607K | Buy |
+1,191
| New | +$607K | 0.07% | 242 |
|
|
2021
Q3 | $792K | Sell |
1,062
-80
| -7% | -$59.7K | 0.08% | 214 |
|
|
2021
Q2 | $736K | Buy |
1,142
+149
| +15% | +$96K | 0.07% | 227 |
|
|
2021
Q1 | $598K | Buy |
993
+158
| +19% | +$95.2K | 0.07% | 232 |
|
|
2020
Q4 | $531K | Buy |
835
+89
| +12% | +$56.6K | 0.06% | 243 |
|
|
2020
Q3 | $470K | Buy |
746
+91
| +14% | +$57.3K | 0.09% | 197 |
|
|
2020
Q2 | $298K | Buy |
655
+121
| +23% | +$55.1K | 0.06% | 246 |
|
|
2020
Q1 | $231K | Buy |
+534
| New | +$231K | 0.06% | 267 |
|
|
2019
Q4 | – | Sell |
-410
| Closed | -$144K | – | 380 |
|
|
2019
Q3 | $144K | Buy |
410
+15
| +4% | +$5.27K | 0.03% | 373 |
|
|
2019
Q2 | $123K | Buy |
+395
| New | +$123K | 0.03% | 404 |
|